DESAI VEERAL (Chief Strategy & Dev. Officer) sold 31.6% of their position (121K shares) of AGILON HEALTH, INC. on the open market
Open‑market sale worth $3.51M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/15/2021ACC: 0001209191-21-056200
Officer· Chief Strategy & Dev. Officer
Since Apr 2021
-121K
Net shares
Net seller
$3.51M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
121K acquired · 242K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+121K
Price / share
$1.00
Trade value
$121K
% of position
46.2%
9/14/2021
261.96K→382.96K
Common Stock
Direct
Shares
−121K
Price / share
$28.98
Trade value
$3.51M
% of position
31.6%
9/14/2021
382.96K→261.96K
Total
Net shares
+0.00
Net value
-$3.39M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/14/2021 | M · Option Exercise | +121K | $1.00 | $121K | 46.2% | 261.96K | 382.96K |
| Common Stock Direct | 9/14/2021 | S · Sale | −121K | $28.98 | $3.51M | 31.6% | 382.96K | 261.96K |
| Total | +0.00 | -$3.39M | ||||||
Derivative Transactions1
Options (Rights to Buy)
Direct
Converts to
Common Stock
121K shares
Shares
−121K
Strike price
1.00
Held after
1.08M
Exercisable
—
9/14/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Options (Rights to Buy) Direct | Common Stock121K shares | 9/14/2021 | M · Option Exercise | −121K | 1.00 | — | 1.08M |